View Policies Current Attempt in Progress Wildhorse Pharmaceuticals entered into a licensing agreement with Zenith Lab for a new drug under development. Wildhorse will receive $8550000 if the new drug receives FDA approval . Based on prior approval, Wildhorse determines that it is 80% likely that the drug will gain approval. The transaction price of this arrangement should be $8550000 OSO until approval is received. $6840000 $1710000 Save for Later Attempts: 0 of 1 used Subtnit